Breast cancer is now the most commonly diagnosed cancer in the world.
While we have advanced care for breast cancer, treatment options such as surgery, chemotherapy, and radiation are associated with significant side effects and are costly for the healthcare system.
To mark Breast Cancer Awareness month, the Foundation partnered with Breast Cancer Alliance (BCA) to explain how emerging immunotherapy research is providing hope to more effectively treat breast cancer.
The Foundation and BCA are funding groundbreaking research to treat breast cancer, and we are partnering to share knowledge with the understanding that combination therapies, such as those you will hear about on the webinar, are the future. We are also committed to advancing health equity and ensuring access to these groundbreaking therapies.
Presentations and Speakers
“Treatment of Breast Tumors at The University of Virginia with Focused Ultrasound Ablation”
David R. Brenin, MD
University of Virginia (UVA Health)
M.C. Wilhelm Professor in Diseases of the Breast
Division Chief of Breast and Melanoma Surgery
Co-Director, UVA Focused Ultrasound Cancer Immunotherapy Center
The UVA Focused Ultrasound Cancer Immunotherapy Center is the world’s first center dedicated specifically to advancing focused ultrasound and cancer immunotherapy treatments that could revolutionize 21st-century cancer care.
“Tempering the Hostile Tumor Microenvironment to Boost Immunotherapy Outcomes in Triple-Negative Breast Cancer”
Scott Abrams, PhD
Roswell Park Comprehensive Cancer Center
Professor of Oncology, Department of Immunology
Co-Leader, Tumor Immunology and Immunotherapy CCSG Program
Michael Nemeth, PhD
Roswell Park Comprehensive Cancer Center
Assistant Professor of Oncology, Department of Immunology
Co-Chair, Leukemia Translational Research Group
Moderator
Natasha Sheybani, PhD
University of Virginia
Assistant Professor, Biomedical Engineering
Research Director, UVA Focused Ultrasound Cancer Immunotherapy Center